
New Corporate Member
IPC is pleased to welcome AnaptysBio as a Bronze Level Corporate Member!
IPC is pleased to welcome AnaptysBio as a Bronze Level Corporate Member!
Three councilors join the group of IPC experts who are working to advance knowledge and enhance the care psoriasis patients around the world.
The 2022 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 24 – Tuesday, March 29 in Boston, Massachusetts. The program was packed with sessions showcasing the latest innovations in dermatology and venereology. Grace Hile, MD, has written a congress report with summaries of eleven psoriasis-focused presentations. You can download the full report or read on for a brief look at some of the highlights.
IPC Councilor, Carlo Pincelli, MD, shares his expert opinion on innovative research that connects insights into immunopathogenesis with genetics and modes of action of treatments.
Amgen presents new data on the efficacy of apremilast in patients with mild to moderate plaque psoriasis and in patients with palmoplantar pustulosis.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the initiation of VISIBLE. VISIBLE is a first-of-its-kind, large-scale prospective clinical study dedicated to generating key disease insights among Black, Hispanic, Asian, Indigenous, and other people of color.
The Psoriasis: from Gene to Clinic International Congress provides a forum for psoriasis experts from around the world to present and discuss cutting-edge issues. You can download the full report or read a summary of some of the highlights.
A research group led by Catherine Smith from St John’s Institute of Dermatology described humoral and cellular immunity.
It is not fully understood the impact that COVID-19 has on psoriasis patients.
IPC is pleased to welcome Arcutis Biotherapeutics, Inc. as a 2022 Bronze Level Corporate Member.
Meet the three new key opinion leaders who have been elected to join our board.
IPC’s newly appointed appointed officers take their roles beginning January 1, 2022.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |